Cardiotoxicity of β-mimetic catecholamines during ontogenetic development - possible risks of antenatal therapy

Canadian Journal of Physiology and Pharmacology
B OstádalF Kolár


Catecholamines are involved in the regulation of a wide variety of vital functions. The β-adrenergic receptor (β-AR) - adenylyl cyclase system has been identified early in embryogenesis before the heart has received adrenergic innervation. The structure of β-receptors in the immature myocardium is similar to that in adults; there are, however, significant quantitative developmental changes in the inotropic and chronotropic responsiveness. Information on the toxic effect of the β-AR agonists in the immature heart is surprisingly scarce, even though these agents are used in clinical practice both during pregnancy and in early postnatal development. Large doses of β-AR agonists induce malformations of the cardiovascular system; the type of change depends upon the time at which the β-AR agonist was administered during embryogenesis. During postnatal ontogeny, the cardiotoxicity of β-AR agonists increased from birth to adulthood. It seems likely that despite interspecies differences, developmental changes in the cardiac sensitivity to β-AR agonists may exist in all mammals, depending on the degree of maturation of the system involved in β-adrenergic signaling. All the existing data draw attention to the possible harmful consequences...Continue Reading


Nov 1, 1975·Journal of Molecular and Cellular Cardiology·J C Yates, N S Dhalla
Jan 1, 1978·Journal of Molecular and Cellular Cardiology·N S DhallaA Singh
Jan 1, 1975·Developmental Biology·M J McLeanN Sperelakis
Oct 1, 1979·European Journal of Pharmacology·F M ChenW R Roeske
Nov 1, 1979·Journal of Molecular and Cellular Cardiology·B OstádalA Wollenberger
Jul 1, 1976·Journal of Molecular and Cellular Cardiology·B Ostádal Rychterová
Dec 15, 1975·Experientia·G Gennser, W Von Studnitz
Jul 1, 1992·Canadian Journal of Physiology and Pharmacology·I Ostádalová, B Ostádal
Jul 1, 1985·Journal of Molecular and Cellular Cardiology·L H OpieR Barsacchi
Jan 1, 1985·Pediatric Research·C G Hatjis
Apr 1, 1985·Journal of Molecular and Cellular Cardiology·S B MatthewsA K Campbell
Jul 1, 1986·Canadian Journal of Physiology and Pharmacology·T JanatováE G Krause
Feb 1, 1987·Journal of Molecular and Cellular Cardiology·H OkudaA Takao
Jan 1, 1986·Pediatric Cardiology·J SkovránekJ Procházka
Apr 1, 1985·Journal of Molecular and Cellular Cardiology·G Rona
Feb 1, 1986·British Journal of Obstetrics and Gynaecology·M Hadders-AlgraH J Huisjes
Jan 1, 1969·American Heart Journal·H C StantonE D Mayfield
Nov 1, 1974·Clinical Pharmacology and Therapeutics·D KadarA W Conn
Jan 1, 1968·Histochemie. Histochemistry. Histochimie·T H Schiebler, R Heene
Jan 1, 1981·Pharmacology & Therapeutics·W R Roeske, K Wildenthal
Jan 1, 1980·British Journal of Pharmacology·S P Baker, L T Potter
Feb 1, 1981·The Journal of Clinical Investigation·S G RocksonS F Vatner
Jan 1, 1983·Pharmacology & Therapeutics·N Sperelakis, A J Pappano
Dec 1, 1983·American Journal of Obstetrics and Gynecology·S N CaritisL K Wong
Jan 1, 1982·The American Journal of Physiology·I S ParkD J Driscoll
Feb 1, 1995·Journal of Cardiovascular Pharmacology·T AkitaR W Joyner
Apr 13, 1995·Nature·S A ThomasR D Palmiter

Related Concepts

MRNA Maturation
Catecholamine [EPC]
Late Effect of Medical Intervention
Regulation of Biological Process
Muscle Innervation, Function
Cardiovascular System
Antenatal Screening Procedures
Catecholamines Measurement
Chronotropism, Cardiac

Related Feeds

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.


Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Related Papers

Biomedica Biochimica Acta
B OstádalI Ostádalová
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
H Itoh
Proceedings of the National Academy of Sciences of the United States of America
D K RohrerB K Kobilka
Patologicheskaia fiziologiia i èksperimental'naia terapiia
M G Pshennikova
© 2020 Meta ULC. All rights reserved